In conclusion, these data indicate that the PTSD‐like phenotypes observed in Fmn2−/− mice are not linked to substantial changes in gene expression, while aberrant gene expression is accelerated in the context of aging as an additional AD risk factor. This evidence concerns the gene FMN2 and Alzheimer disease.